Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets - Wikidata - awgldk - TriplyDB

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

http://www.wikidata.org/entity/Q28140238

about

Recent advances of novel targeted therapy in non-small cell lung cancer Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions Monoclonal antibodies targeting cancer: 'magic bullets' or just the trigger?Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo Rituximab: mechanism of action The use of lentinan for treating gastric cancer The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors Immunotherapy of systemic sclerosis Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer The antiinflammatory activity of IgG: the intravenous IgG paradox Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines Recognition and Regulation of T Cells by NK Cells Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects Influence of immunoglobulin isotype on therapeutic antibody function The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Immune Modulation in Hematologic Malignancies Enhancing Cancer Immunotherapy Via Activation of Innate Immunity NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy The role of Fc-FcγR interactions in IgG-mediated microbial neutralization HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells Immunotherapy for prostate cancer: recent developments and future challenges Complement in monoclonal antibody therapy of cancer Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity Humoral-targeted immunotherapies in multiple sclerosis Translating basic mechanisms of IgG effector activity into next generation cancer therapies Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma Pharmacogenomics of breast cancer therapy: an update Targeting and utilizing primary tumors as live vaccines: changing strategies Tumor antigen-specific monoclonal antibodies and induction of T-cell immunity

P2860

Q21092930-9E809C73-77DE-442E-B7BB-F747C80A568F Q21131216-8DC719A7-EBC2-4700-B29F-448893DCEF19 Q24294932-993F18B2-353D-4A05-849C-D5C2C8C379FB Q24532135-3AF9A818-1884-422C-A65D-1DCAC25D51D6 Q24542471-20750D63-D33E-4938-A9C5-D40BBC077EA9 Q24568302-67C14466-257F-4506-B4FF-120F8F406ED9 Q24607358-259EF956-769A-4122-8856-80FEAB06A37F Q24619416-5B7DD826-0CC6-465D-876F-B298CB91897A Q24631515-DAC94543-ED2C-4E34-B328-375F763FA407 Q24634395-E67AFFB7-E5EA-48FA-AC7D-E562D9EA04D2 Q24650717-7D2896E7-0D1F-40E9-8097-AB4B275147AF Q24655389-1FD1DC2C-FA3D-40E5-8B2E-7552CC8F1515 Q24656159-503A46A8-682D-4261-B69F-DFD88C0374CC Q24676548-56D36622-B7F1-4679-92C3-B9F501F84A32 Q24681992-EB6270B7-0674-4C6E-A20A-F5B140F83122 Q24795614-91ACE8BD-E20B-498A-B90C-AD2B3F49B6B3 Q24804837-9420513E-6B02-457B-A115-E8C9C060126C Q26742166-0C37A735-A95B-4EBB-821C-86BECA38F73D Q26751473-E11AFEBC-38AC-4CD8-9F2F-61B55025ABEB Q26770815-7CB56149-85DF-44AD-9CB1-2B1351097197 Q26772080-65396422-6FE8-4155-9E66-ADA26D1757EA Q26774678-277E2CCC-AE1E-4460-B037-EEA03C451DEA Q26776198-1CDAD6F1-F3D9-4DC6-9993-29FFD6C0ECD5 Q26783175-FEA00BC5-6357-4B0F-9B7E-C9AE0F213AC4 Q26796307-4080C4BE-9BF4-4564-AC5F-4E65C6B40B7A Q26796313-A0F78065-AFB7-4E6A-BE0D-692BDC30BE46 Q26797345-132C0563-33EF-4EF1-9D1E-0D72E9EE4BA8 Q26797466-31D6B866-016A-4BDA-A8E3-E2E1D7FA7005 Q26822730-6463B44B-98DF-4805-9B7B-4E0708A2CE63 Q26852287-55558D18-59BA-4794-8FA2-092B33A5F47B Q26852388-5A8610BA-C100-4FA8-A9AD-6DB059DB761E Q26860800-19FEA5AE-1DB5-4FE1-BDE4-7AB3001AC6B3 Q26862220-15C59A13-AC27-4D7D-B43A-9E2B455A3E46 Q26865971-EEEA07C8-A61F-4E65-860D-4F7A5852FA2B Q26991899-50D9BDAB-C690-405C-BF68-2B1BF476518C Q26995399-2D4F087D-7D7C-433B-8855-3386044B8199 Q26999011-60567C0E-8A67-4E9D-B8E5-03A59D1EED66 Q27006783-D7FD78EE-7DF5-4350-945F-F26D47741549 Q27009348-B03DAEB5-140E-4A80-A8AE-C405632E923A Q27009908-0C1CDF3D-24FB-4E40-9130-58DBCD9FF0E3

P2860

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

http://www.wikidata.org/entity/Q28140238

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@ast

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@en

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@nl

type

label

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@ast

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@en

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@nl

prefLabel

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@ast

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@en

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@nl

P1433

Q28140238-D247D750-5EB1-484B-BAEA-99D7E7616F9A

P1476

Q28140238-A89FDBAC-707D-4481-968A-8A46AC38A81F

P2093

Q28140238-0B4707DD-8706-4EF2-8D95-C461C6D18AAF

Q28140238-89F16F6A-E8ED-4B37-813F-6EDCB4FD4050

Q28140238-B941B9B5-D86A-4CC5-B493-9BC49102B0CD

Q28140238-C7780E80-467D-463A-82C5-A9E8A93B7AC0

P2860

Q28140238-01F63506-8DF4-4435-A928-55E2D2A15A26

Q28140238-0981C7C7-F816-499B-A863-5FC08E77494F

Q28140238-1B91B90C-C98E-4341-AADB-B04A528A66F6

Q28140238-3A65CAB2-B328-48F5-9C8A-E93F55085C40

Q28140238-9155FEAB-8B1A-4695-AB11-719278144681

Q28140238-C4C9B85A-807F-463B-9431-8AC1C43967FB

Q28140238-E40771E2-796F-436A-AF07-A1B62E4932C1

Q28140238-FD95E505-26F8-41EA-B25B-080668473044

P2888

Q28140238-465DDC45-C136-4A0D-98E5-55206866DE90

P304

Q28140238-614717A1-9988-4CE3-8170-30C78ABB438D

P31

Q28140238-7242CF10-C51B-4F52-B210-A8FBF0A7B0AD

P3181

Q28140238-F2528980-7B1F-44ED-8779-139B512F6703

P356

Q28140238-D8CD8F71-696B-4107-A7B8-5CC43F8AFF90

P407

Q28140238-97E65976-542B-476B-82A1-1ABC1DF4B03A

P433

Q28140238-9D845E1F-885A-4FBF-A55A-FDE7A9BD69DE

P478

Q28140238-51D00D4D-2AD1-4D57-827F-A56D3D02AA78

P577

Q28140238-2873E853-E4F3-426E-8C9C-D8419E76DCD2

P5875

Q28140238-85B3B39E-8705-4EBF-BA83-8AEBA052DF94

P698

Q28140238-EF2AAEBE-2B80-4576-9572-D820F3DA0871

P921

Q28140238-8266A908-D0CE-45AB-A86E-099C871CFEA7

P3181

P356

P1433

Nature Medicine

P1476

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

@en

P2093

J V Ravetch

http://www.w3.org/2001/XMLSchema#string

L G Presta

http://www.w3.org/2001/XMLSchema#string

R A Clynes

http://www.w3.org/2001/XMLSchema#string

T L Towers

http://www.w3.org/2001/XMLSchema#string

P2860

Humanization of an anti-p185HER2 antibody for human cancer therapy

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice

Fc receptors are required in passive and active immunity to melanoma.

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.

FcR gamma chain deletion results in pleiotrophic effector cell defects.

Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody.

Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

P2888

P304

443-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

521063

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/74704

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12574468

http://www.w3.org/2001/XMLSchema#string

P698

10742152

http://www.w3.org/2001/XMLSchema#string

P921